BCG: A Discussion of Its Use and Application |
Contents
Introductory Chapters | 1 |
B Clinical Considerations in Vaccination against Tuberculosis | 12 |
12 | 29 |
Copyright | |
17 other sections not shown
Common terms and phrases
abscesses acid-fast bacilli Acta tuberc adenitis adults age groups allergy Amer animals Aronson bacteria bacteriological BCG vaccination Calmette chemotherapy cination clinical complications controls culosis cultures cutaneous Danish developed diagnosis disease doses of BCG effect of BCG erythema nodosum experimental experiments Gernez-Rieux guinea-pigs immunity incidence of tuberculosis individuals induration inoculation Inst intracutaneous intradermal isoniazid Japan lesions lupus lupus vulgaris lymph nodes Mantoux Medical Research Council method morbidity multiple puncture observed occurred organisms parenteral Paris Pasteur Pasteur Institute patients period pleurisy population present primary tuberculosis protection pulmonary lesions pulmonary tuberculosis reactors received BCG regional adenitis reported resistance Rosemberg scand scarifications skin strain streptomycin suppuration tion tissues treated treatment tubercle bacilli tubercles tubercles tuberculin conversion tuberculin negative tuberculin positive tuberculin reaction tuberculin sensitivity tuberculin test tuberculous infection unvaccinated vaccinated children vaccinated group vaccinated persons vaccination with BCG vaccinotherapy virulent vole bacillus vaccine weeks X-ray